Abstract
7003Background: We have previously reported high anti-tumor activity of CD19-targeted 19-28z chimeric antigen receptor (CAR) modified T cells in adult patients (pts) with relapsed or refractory (R/...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.